This could potentially exacerbate the metabolic effects of sarcopenic obesity given the decreased glucose uptake resulting from decreased muscle mass heightened by the inhibitory action of myostatin on insulin sensitivity. Here, MSTN is linked to obesity due to melanocortin 4 receptor deficiency.